Our customer service representatives are available 24 hours a day, 7 days a week.
CD Formulation is a leading provider of preclinical and clinical testing services for generic veterinary drugs. Through our integrated capabilities in pharmacokinetics, formulation development and bioanalytical sciences, we conduct comprehensive bioequivalence studies across relevant species. In addition to standalone bioequivalence trials, we offer full generic drug development programs including manufacturing process validation and stability testing.
Consistency evaluation, also known as bioequivalence testing, establishes that a generic veterinary drug is interchangeable with the branded reference product. It demonstrates that the generic has consistent quality, safety and efficacy. Studies involve administering the generic and reference to animals and comparing their pharmacokinetic profiles. Parameters like maximum concentration, time to peak and overall exposure are measured to ensure they are within acceptable equivalence ranges.
Consistency Evaluation of Quality |
|
Consistency Evaluation of Efficacy |
|
We conduct research on generic formulations of antibiotics and antimicrobials used in veterinary medicine, aiming to enhance their efficacy, safety, and compliance. This includes optimization of drug delivery systems, dosage forms, and combination therapies to combat bacterial infections in animals.
Our research focuses on developing generic versions of anti-inflammatory drugs for veterinary use, including nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. We aim to improve their bioavailability, duration of action, and minimize potential side effects.
We investigate and optimize generic formulations of parasiticides, such as anthelmintics and ectoparasiticides, used to treat and prevent infestations in animals. Our research emphasizes improving drug delivery systems, efficacy against various parasites, and minimizing resistance development.
Our research explores generic alternatives to cardiac medications used in veterinary practice, including drugs for heart failure, arrhythmias, and hypertension. The focus is on developing formulations with improved bioavailability, controlled release, and enhanced patient compliance.
CD Formulation has extensive experience conducting in vitro dissolution testing, bioanalytical method development and validation, formulation design, and in vivo bioequivalence studies. If you are looking to assess the consistency of your veterinary generic drugs, please feel free to contact us!